BCL6 and neoplasm: Both miR-10a and miR-187 act as tumor suppressors by regulating BCL6 expression through induction of cell apoptosis as shown in cell culture and tumor microarray studies suggesting these miRNAs could be exploited as a novel therapeutic target for DLBCL treatment [98,99].